New Ibex Report Highlights Patient Concerns About Cancer Diagnoses
Ibex Medical Analytics’ inaugural Patient Insight Report on Cancer Diagnostics reveals widespread concerns about cancer diagnoses.
Ibex Medical Analytics’ inaugural Patient Insight Report on Cancer Diagnostics reveals widespread concerns about cancer diagnoses.
XiFin has added new features and insights to its Lab Volume Index (LVI), with a deeper dive in the post-pandemic diagnostic landscape.
A new study reported data on a number of hospitalized COVID patients and correlates their serum thyroid hormone levels with biomarkers to critical illness.Â
Researchers developed a first-of-its-kind molecular catalog of cells in healthy lungs and the lungs of people with cystic fibrosis.
Read MoreThe OMNY Health Platform is a healthcare data-sharing solution that accelerates innovation by connecting the healthcare ecosystem with opportunities to connect anonymized data with researchers from life sciences organizations.
Read MoreResearchers found low blood levels of immune cells called lymphocytes, in combination with higher levels of inflammation on PET/CT scans, are indicators of active sarcoidosis—an inflammatory disease that attacks multiple organs, particularly the lungs and lymph nodes.
Read MoreAkershus University Hospital and Bio-Me are collaborating on a study of the long-term effects of covid-19 in adolescents and young adults, investigating the involvement of the microbiome.
Read MoreNew research findings offer hope that a new test could be developed to diagnose Parkinson’s through a simple and painless skin swab.
Read MoreThe study suggests that such liquid biopsies could help personalize treatment for oligometastatic colorectal cancer.
Read MoreNew research has shown that results of blood tests routinely performed by GPs everywhere contain a hidden fingerprint that can identify people silently developing potentially fatal liver cirrhosis.
Read MoreJ. Craig Venter shares in Scientific American his experience mapping the human genome and his frustrations with how little progress we’ve made in putting it to use 20 years later.
Read MoreThe Gibco CTS OpTmizer Pro Serum Free Media is a first-of-its-kind media-solution that targets the metabolism of healthy donor cells, making it ideally suited for use in the production of allogeneic, off-the-shelf cell therapies.
Read MoreThe UT Dallas researchers’ sensor is a portable device that monitors a panel of five immune biomarkers using only a single drop of blood plasma, making a sepsis diagnosis available within minutes.
Read MoreNew research has demonstrated that a simple, cheap test can help identify who is at risk of developing colorectal cancer, aiding early diagnosis and potentially saving lives.
Read MoreOxford Immunotec will perform T cell testing on participants receiving Valneva’s inactivated whole-virus covid-19 vaccine candidate with the research-use-only T-SPOT Discovery SARS-CoV-2 test.
Read MoreRresearchers provide convincing evidence that an in-house developed blood test for Alzheimer’s disease can detect the disease early and track its course, which has major implications for a potential use in clinical practice and treatment trials.
Read MoreUsing a blood test, a research team has predicted the risk of Alzheimer’s disease in people who were clinically diagnosed as not having Alzheimer’s disease but who perceived themselves as cognitively impaired.
Read MoreUniversity of Birmingham Enterprise has filed a patent application covering the method and its use in diagnostic equipment, and is now seeking to license the patent for rapid product development.
Read More